Core Points - Neurocrine Biosciences held its 2025 R&D Day, emphasizing the importance of the event for stakeholders [1] - The event featured key executives including the CEO, Chief Medical Officer, and Chief Scientific Officer, highlighting the leadership team's experience [2][3] - Dr. John Krystal, a prominent figure in neurology and psychiatry, participated in the event, indicating the company's commitment to collaboration with leading experts [3]